Creative Doctors ๐Ÿ–ค
4.19K subscribers
968 photos
27 videos
358 files
458 links
Med notes ๐ŸŽถ
Download Telegram
๐Ÿ‘‘๐Ÿ‘‘Excitatory post-synaptic potential (EPSP):

excitatory neurotransmitter as Glutamate or Acetylcholine

๐Ÿง‘โ€โš•๏ธ๐Ÿง‘โ€โš•๏ธlead to opening of ligand gated ion channels lead to depolarisation
๐Ÿ‘1
๐Ÿง ๐Ÿง Types of Synaptic Transmission

๐Ÿ‘ป1- Fast Synaptic Transmission

๐Ÿ‘ป2-Slow Synaptic Transmission

โ˜๐Ÿปโ˜๐ŸปA-Direct G-protein gating

B- Gating via an intracellular messenger:
๐Ÿ‘1
#MR_s3 โ˜๏ธโ˜๏ธโ˜๏ธโ˜๏ธโ˜๏ธ
๐Ÿ‘1
๐Ÿ—ฃ๐Ÿ—ฃWhat would happen to the membrane potential if there was an increase in the permeability of the membrane to K+ ions ?


๐Ÿ‘ฑ๐Ÿปโ€โ™€๏ธ๐Ÿ‘ฑ๐Ÿปโ€โ™€๏ธOutflow of K+ ions โ†’ inside become more negative โ†’ hyperpolarization
๐Ÿ‘1
๐Ÿ‘ป๐Ÿ‘ปWhat contribution does the Na+-K+-ATPase make to the maintenance of the resting membrane potential?


๐Ÿ‘ฉ๐Ÿปโ€โš•๏ธ๐Ÿ‘ฉ๐Ÿปโ€โš•๏ธThe activity of Na+ / K+ ATPase maintain normal concertation gradient. After hyperpolarization, Na+ inside is higher than normal and K+ outside is also higher than normal, so (Na+ / K+ ATPase) will direct (3Na+ outward) and (2K+ inward) restoring the normal membrane potential and concentrations
๐Ÿ‘1
๐Ÿ•ต๏ธโ€โ™‚๏ธ๐Ÿ•ต๏ธโ€โ™‚๏ธ resting membrane potential is established depending on ???



๐Ÿ‘ฉ๐Ÿปโ€โš•๏ธ๐Ÿ‘ฉ๐Ÿปโ€โš•๏ธ1. Which types of channels are open.

2. On the ionic concentration across cell membrane.
๐Ÿ‘1
๐Ÿฆ‹๐Ÿฆ‹body_fluid-compartment


๐Ÿ˜Šุชูƒูˆู† ู†ุณุจุฉ ุงู„total body water ู‡ูŠ42L๐ŸŠโ€โ™‚๏ธ

๐ŸŒนุงู…ุง ู†ุณุจุฉ ุงู„ICF ุชูƒูˆู† 28L๐Ÿค“

๐ŸŒนูˆุงู„ECF ุชูƒูˆู† 14L๐Ÿ‘

๐ŸŒนุงู…ุง ุงู„ุจู„ุงุฒู…ุง ูุชุดูƒู„ 3L ูˆุงู„ISF ุชุดูƒู„11L

๐ŸŒนูˆุงุญู†ู‡ ุณุจู‚ ูˆุงู† ูƒู„ู†ู‡ ุงู†ูˆ ุงู„ECF ุชู‚ุณู… ุงู„ู‰ ุจู„ุงุฒู…ุง ูˆISF
ุงู…ุง ุงู„ICF ูˆุงู„ู„ูŠ ุชุดูƒู„28L ุฑุงุญ ุชูƒูˆู† ูƒู„ู‡ุง ุจุฏุงุฎู„ ุงู„ุฎู„ูŠู‡


ุจุงู„ุญู„ูˆู„ ู…ู‚ุณู… ุงู„extra ุงู„ูŠ ุซู„ุงุซู‡ ู‡ู… ุนุงุฏูŠ ูŠุตูŠุฑ ๐Ÿ˜Œ๐Ÿ˜Œ
#MR_s2 โ˜๏ธโ˜๏ธโ˜๏ธโ˜๏ธ
๐Ÿ’ซFactors affecting bioavailability of drug ??

๐Ÿฅ€First-pass hepatic metabolism
๐Ÿฅ€Solubility of the drug
๐Ÿฅ€Chemical instability
๐Ÿฅ€Nature of the drug formulation

#MR_s8
๐Ÿฆ‹avoid the parenteal drug IV&sublingual buccal,rectal drug??

๐ŸŒšโžก๏ธbecause this drug enter directly into the systemic circulation &rest of the body
***drugs administered orally are first exposed to the liver and extensively metabolized before reaching the rest of the body
โค๏ธโค๏ธ
#MR_s8
Larg RMP ๐Ÿ‘‰more negative membrane potential ๐Ÿ‘‰highe thereshold ๐Ÿ‘‰ less excitable

#MR_S4
Importance of absolute refrectory period ARP ุŸุŸุŸุŸ

๐ŸŒธPrevent over firing
๐ŸŒธMake the action potential in one way


#MR_S4
Properties of the axon that lead to a high conduction velocity include:

โ€ข A high membrane resistance.(Rm)
โ€ข A low membrane capacitance.
โ€ข A large axon diameter (this leads to a low cytoplasmic resistance).
Propagation of Action Potential:
Depends on:

1- Distribution of ion channel.
2- The diameter of the axon.
3- The presence of myelin sheath.
The myelin sheath
ู‡ูˆ ุนุจุงุฑู‡ ุนู† ุฎู„ุงูŠุง ุชุญูŠุท ุจู„ axon ูˆุชุนุชุจุฑ ูƒุนุงุฒู„ ูˆู‡ุฐู‡ ุงู„ุฎู„ุงูŠุง ุชุชูƒูˆู† ู…ู†
Schwan cell๐Ÿ‘‰๐Ÿปpns
Oligodendrocyte ๐Ÿ‘‰๐Ÿปcns
ูˆู‡ุฐู‡ ุงู„ุฎู„ุงูŠุง ูŠุญุชูˆูŠ ุงู„plasma membrane ู…ุงู„ุชู‡ุง ุนู„ู‰ ูƒู…ูŠู‡ ูƒุจูŠุฑู‡ ู…ู† ุงู„sphengomyline lipid ูˆุงู„ูŠ ูŠูƒูˆู† ู‚ู„ูŠู„ ุงู„ู†ูุงุฐูŠู‡ ู„ุฐู„ูƒ ูŠุนุชุจุฑ ูƒุนุงุฒู„ ูˆุชุฃุซูŠุฑู‡ ูŠูƒูˆู†

1-Low capacitance
2-Increase membrane resistance Rm

ูˆุจุฐู„ูƒ ูŠูƒูˆู† high Conduction velocity

action potential only generated in small region called nodes of ranvier

ุงู‡ู†ุง ุญุฑูƒุฉ ุงู„action potential ุจู„ mylinated fiber ุชุณู…ู‰ ุจู„ saltatory conduction

ุงู…ุง ุงู„ุญุฑูƒู‡ ุจู„unmylinated ุชุณู…ู‰ local circuit
#MR_s8 โ˜๏ธโ˜๏ธ
โ€ขAGONIST ๐Ÿ ๐Ÿ a naturally occurring small molecule or a drug that binds to a site on a receptor protein and activates it


ANTGAONIST๐Ÿ ๐Ÿ  occupy the receptor but do not stimulate it and may stabilize the receptor in the inactive state

Partial agonist ๐Ÿ ๐Ÿ cause partial activation of the receptor

#MR_s8